House Appropriators Go Low On FDA's Budget

Appropriation set for CFSAN and ORA’s related field activities is $1.16bn, up slightly from the FY2021 level of $1.1bn, and for CDER and ORA’s related activities is $2.1bn, up $100m from current funding.

House appropriators recommend $6.29bn for the US Food and Drug Administration’s fiscal year 2022 budget, up $257m from its current budget but more than $200m less than the agency requested.

A bill with the FDA appropriation along with the Department of Agriculture and related agencies sets FY2022 spending for the...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation